• KemPharm Receives $10M Milestone for FDA Approval of Azstarys contractpharma
    April 23, 2021
    KemPharm Inc., a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, has confirmed receipt of a regulatory milestone payment of $10 million for the FDA approval of Azstarys in accordance with the recently ...
PharmaSources Customer Service